-
1
-
-
84901616858
-
Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S
-
R. J. Wong, R. Cheung, A. Ahmed, Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. Hepatology 59, 2188-2195 (2014).
-
(2014)
Hepatology
, vol.59
, pp. 2188-2195
-
-
Wong, R.J.1
Cheung, R.2
Ahmed, A.3
-
3
-
-
84930788424
-
Nonalcoholic fatty liver disease: A systematic review
-
M. E. Rinella, Nonalcoholic fatty liver disease: A systematic review. JAMA 313, 2263-2273 (2015).
-
(2015)
JAMA
, vol.313
, pp. 2263-2273
-
-
Rinella, M.E.1
-
4
-
-
84941929364
-
Epidemiology and natural history of nonalcoholic fatty liver disease
-
S. K. Satapathy, A. J. Sanyal, Epidemiology and natural history of nonalcoholic fatty liver disease. Semin. Liver Dis. 35, 221-235 (2015).
-
(2015)
Semin. Liver Dis
, vol.35
, pp. 221-235
-
-
Satapathy, S.K.1
Sanyal, A.J.2
-
5
-
-
33750002388
-
Prevalence of fatty liver in children and adolescents
-
J. B. Schwimmer, R. Deutsch, T. Kahen, J. E. Lavine, C. Stanley, C. Behling, Prevalence of fatty liver in children and adolescents. Pediatrics 118, 1388-1393 (2006).
-
(2006)
Pediatrics
, vol.118
, pp. 1388-1393
-
-
Schwimmer, J.B.1
Deutsch, R.2
Kahen, T.3
Lavine, J.E.4
Stanley, C.5
Behling, C.6
-
6
-
-
84861591910
-
The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association
-
American Association for the Study of Liver Diseases, and American College of Gastroenterology
-
N. Chalasani, Z. Younossi, J. E. Lavine, A. M. Diehl, E. M. Brunt, K. Cusi, M. Charlton, A. J. Sanyal, The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142, 1592-1609 (2012).
-
(2012)
Gastroenterology
, vol.142
, pp. 1592-1609
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
Diehl, A.M.4
Brunt, E.M.5
Cusi, K.6
Charlton, M.7
Sanyal, A.J.8
-
7
-
-
84927796763
-
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
-
S. McPherson, T. Hardy, E. Henderson, A. D. Burt, C. P. Day, Q. M. Anstee, Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management. J. Hepatol. 62, 1148-1155 (2015).
-
(2015)
J. Hepatol
, vol.62
, pp. 1148-1155
-
-
McPherson, S.1
Hardy, T.2
Henderson, E.3
Burt, A.D.4
Day, C.P.5
Anstee, Q.M.6
-
8
-
-
0031947715
-
Steatohepatitis: A tale of two "hits"?
-
C. P. Day, O. F. W. James, Steatohepatitis: A tale of two "hits"? Gastroenterology 114, 842-845 (1998).
-
(1998)
Gastroenterology
, vol.114
, pp. 842-845
-
-
Day, C.P.1
James, O.F.W.2
-
9
-
-
0016750096
-
Relation of steatosis to cirrhosis
-
H. Thaler, Relation of steatosis to cirrhosis. Clin. Gastroenterol. 4, 273-280 (1975).
-
(1975)
Clin. Gastroenterol.
, vol.4
, pp. 273-280
-
-
Thaler, H.1
-
10
-
-
77955690182
-
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites
-
B. A. Neuschwander-Tetri, Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774-788 (2010).
-
(2010)
Hepatology
, vol.52
, pp. 774-788
-
-
Neuschwander-Tetri, B.A.1
-
11
-
-
84869498671
-
Nonalcoholic fatty liver disease in lean individuals in the United States
-
Z. M. Younossi, M. Stepanova, F. Negro, S. Hallaji, Y. Younossi, B. Lam, M. Srishord, Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine 91, 319-327 (2012).
-
(2012)
Medicine
, vol.91
, pp. 319-327
-
-
Younossi, Z.M.1
Stepanova, M.2
Negro, F.3
Hallaji, S.4
Younossi, Y.5
Lam, B.6
Srishord, M.7
-
12
-
-
84870855668
-
Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults
-
Y.-M. Kwon, S.-W. Oh, S.-s. Hwang, C. Lee, H. Kwon, G. E. Chung, Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am. J. Gastroenterol. 107, 1852-1858 (2012).
-
(2012)
Am. J. Gastroenterol.
, vol.107
, pp. 1852-1858
-
-
Kwon, Y.-M.1
Oh, S.-W.2
Hwang, S.-S.3
Lee, C.4
Kwon, H.5
Chung, G.E.6
-
13
-
-
77952290167
-
Diagnostic performance of body mass index to identify obesity as defined by body adiposity: A systematic review and meta-analysis
-
D. O. Okorodudu, M. F. Jumean, V. M. Montori, A. Romero-Corral, V. K. Somers, P. J. Erwin, F. Lopez-Jimenez, Diagnostic performance of body mass index to identify obesity as defined by body adiposity: A systematic review and meta-analysis. Int. J. Obes. 34, 791-799 (2010).
-
(2010)
Int. J. Obes.
, vol.34
, pp. 791-799
-
-
Okorodudu, D.O.1
Jumean, M.F.2
Montori, V.M.3
Romero-Corral, A.4
Somers, V.K.5
Erwin, P.J.6
Lopez-Jimenez, F.7
-
14
-
-
49649096375
-
Visceral fat: A key mediator of steatohepatitis in metabolic liver disease
-
D. van der Poorten, K.-L. Milner, J. Hui, A. Hodge, M. I. Trenell, J. G. Kench, R. London, T. Peduto, D. J. Chisholm, J. George, Visceral fat: A key mediator of steatohepatitis in metabolic liver disease. Hepatology 48, 449-457 (2008).
-
(2008)
Hepatology
, vol.48
, pp. 449-457
-
-
Poorten Der D.Van1
Milner, K.-L.2
Hui, J.3
Hodge, A.4
Trenell, M.I.5
Kench, J.G.6
London, R.7
Peduto, T.8
Chisholm, D.J.9
George, J.10
-
15
-
-
84892727198
-
What we talk about when we talk about fat
-
E. D. Rosen, B. M. Spiegelman, What we talk about when we talk about fat. Cell 156, 20-44 (2014).
-
(2014)
Cell
, vol.156
, pp. 20-44
-
-
Rosen, E.D.1
Spiegelman, B.M.2
-
16
-
-
84937423157
-
Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals
-
F. Badoud, M. Perreault, M. A. Zulyniak, D. M. Mutch, Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J. 29, 748-758 (2015).
-
(2015)
FASEB J
, vol.29
, pp. 748-758
-
-
Badoud, F.1
Perreault, M.2
Zulyniak, M.A.3
Mutch, D.M.4
-
17
-
-
57349101675
-
A stress signaling pathway in adipose tissue regulates hepatic insulin resistance
-
G. Sabio, M. Das, A. Mora, Z. Zhang, J. Y. Jun, H. J. Ko, T. Barrett, J. K. Kim, R. J. Davis, A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539-1543 (2008).
-
(2008)
Science
, vol.322
, pp. 1539-1543
-
-
Sabio, G.1
Das, M.2
Mora, A.3
Zhang, Z.4
Jun, J.Y.5
Ko, H.J.6
Barrett, T.7
Kim, J.K.8
Davis, R.J.9
-
18
-
-
84938740788
-
Targeting fatty acid metabolism to improve glucose metabolism
-
R. Stinkens, G. H. Goossens, J. W. E. Jocken, E. E. Blaak, Targeting fatty acid metabolism to improve glucose metabolism. Obes. Rev. 16, 715-757 (2015).
-
(2015)
Obes. Rev
, vol.16
, pp. 715-757
-
-
Stinkens, R.1
Goossens, G.H.2
Jocken, J.W.E.3
Blaak, E.E.4
-
19
-
-
64349095231
-
Cold-activated brown adipose tissue in healthy men
-
W. D. van Marken Lichtenbelt, J. W. Vanhommerig, N. M. Smulders, J. M. A. F. L. Drossaerts, G. J. Kemerink, N. D. Bouvy, P. Schrauwen, G. J. Jaap Teule, Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360, 1500-1508 (2009).
-
(2009)
N. Engl. J. Med
, vol.360
, pp. 1500-1508
-
-
Van Lichtenbelt Marken, W.D.1
Vanhommerig, J.W.2
Smulders, N.M.3
Drossaerts, J.M.A.F.L.4
Kemerink, G.J.5
Bouvy, N.D.6
Schrauwen, P.7
Jaap Teule, G.J.8
-
20
-
-
64349123664
-
Functional brown adipose tissue in healthy adults
-
K. A. Virtanen, M. E. Lidell, J. Orava, M. Heglind, R. Westergren, T. Niemi, M. Taittonen, J. Laine, N.-J. Savisto, S. Enerbäck, P. Nuutila, Functional brown adipose tissue in healthy adults. N. Engl. J. Med. 360, 1518-1525 (2009).
-
(2009)
N. Engl. J. Med
, vol.360
, pp. 1518-1525
-
-
Virtanen, K.A.1
Lidell, M.E.2
Orava, J.3
Heglind, M.4
Westergren, R.5
Niemi, T.6
Taittonen, M.7
Laine, J.8
Savisto, N.-J.9
Enerbäck, S.10
Nuutila, P.11
-
21
-
-
84864287504
-
Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human
-
J. Wu, P. Boström, L. M. Sparks, L. Ye, J. H. Choi, A.-H. Giang, M. Khandekar, K. A. Virtanen, P. Nuutila, G. Schaart, K. Huang, H. Tu, W. D. van Marken Lichtenbelt, J. Hoeks, S. Enerbäck, P. Schrauwen, B. M. Spiegelman, Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150, 366-376 (2012).
-
(2012)
Cell
, vol.150
, pp. 366-376
-
-
Wu, J.1
Boström, P.2
Sparks, L.M.3
Ye, L.4
Choi, J.H.5
Giang, A.-H.6
Khandekar, M.7
Virtanen, K.A.8
Nuutila, P.9
Schaart, G.10
Huang, K.11
Tu, H.12
Van Lichtenbelt Marken, W.D.13
Hoeks, J.14
Enerbäck, S.15
Schrauwen, P.16
Spiegelman, B.M.17
-
22
-
-
84940830979
-
FTO obesity variant circuitry and adipocyte browning in humans
-
M. Claussnitzer, S. N. Dankel, K.-H. Kim, G. Quon, W. Meuleman, C. Haugen, V. Glunk, I. S. Sousa, J. L. Beaudry, V. Puviindran, N. A. Abdennur, J. Liu, P.-A. Svensson, Y.-H. Hsu, D. J. Drucker, G. Mellgren, C.-C. Hui, H. Hauner, M. Kellis, FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373, 895-907 (2015).
-
(2015)
N. Engl. J. Med
, vol.373
, pp. 895-907
-
-
Claussnitzer, M.1
Dankel, S.N.2
Kim, K.-H.3
Quon, G.4
Meuleman, W.5
Haugen, C.6
Glunk, V.7
Sousa, I.S.8
Beaudry, J.L.9
Puviindran, V.10
Abdennur, N.A.11
Liu, J.12
Svensson, P.-A.13
Hsu, Y.-H.14
Drucker, D.J.15
Mellgren, G.16
Hui, C.-C.17
Hauner, H.18
Kellis, M.19
-
23
-
-
85027909934
-
Adipose tissue browning and metabolic health
-
A. Bartelt, J. Heeren, Adipose tissue browning and metabolic health. Nat. Rev. Endocrinol. 10, 24-36 (2014).
-
(2014)
Nat. Rev. Endocrinol
, vol.10
, pp. 24-36
-
-
Bartelt, A.1
Heeren, J.2
-
24
-
-
84870568785
-
Circulating fibroblast growth factors as metabolic regulators-A critical appraisal
-
B. Angelin, T. E. Larsson, M. Rudling, Circulating fibroblast growth factors as metabolic regulators-A critical appraisal. Cell Metab. 16, 693-705 (2012).
-
(2012)
Cell Metab
, vol.16
, pp. 693-705
-
-
Angelin, B.1
Larsson, T.E.2
Rudling, M.3
-
25
-
-
84931569401
-
Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes
-
L. Berti, M. Irmler, M. Zdichavsky, T. Meile, A. Böhm, N. Stefan, A. Fritsche, J. Beckers, A. Königsrainer, H.-U. Häring, M. H. de Angelis, H. Staiger, Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol. Metab. 4, 519-527 (2015).
-
(2015)
Mol. Metab
, vol.4
, pp. 519-527
-
-
Berti, L.1
Irmler, M.2
Zdichavsky, M.3
Meile, T.4
Böhm, A.5
Stefan, N.6
Fritsche, A.7
Beckers, J.8
Königsrainer, A.9
Häring, H.-U.10
De Angelis, M.H.11
Staiger, H.12
-
26
-
-
77950343252
-
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
-
G. S. Hotamisligil, Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140, 900-917 (2010).
-
(2010)
Cell
, vol.140
, pp. 900-917
-
-
Hotamisligil, G.S.1
-
27
-
-
84884530954
-
Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease
-
C. Koliaki, M. Roden, Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol. Cell. Endocrinol. 379, 35-42 (2013).
-
(2013)
Mol. Cell. Endocrinol
, vol.379
, pp. 35-42
-
-
Koliaki, C.1
Roden, M.2
-
28
-
-
84949959656
-
Heritability of hepatic fibrosis and steatosis based on a prospective twin study
-
Genetics of NAFLD in Twins Consortium
-
R. Loomba, N. Schork, C.-H. Chen, R. Bettencourt, A. Bhatt, B. Ang, P. Nguyen, C. Hernandez, L. Richards, J. Salotti, S. Lin, E. Seki, K. E. Nelson, C. B. Sirlin, D. Brenner; Genetics of NAFLD in Twins Consortium, Heritability of hepatic fibrosis and steatosis based on a prospective twin study. Gastroenterology 149, 1784-1793 (2015).
-
(2015)
Gastroenterology
, vol.149
, pp. 1784-1793
-
-
Loomba, R.1
Schork, N.2
Chen, C.-H.3
Bettencourt, R.4
Bhatt, A.5
Ang, B.6
Nguyen, P.7
Hernandez, C.8
Richards, L.9
Salotti, J.10
Lin, S.11
Seki, E.12
Nelson, K.E.13
Sirlin, C.B.14
Brenner, D.15
-
29
-
-
84949874416
-
Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease
-
K. L. Wood, M. H. Miller, J. F. Dillon, Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease. BMJ Open Gastroenterol. 2, e000019 (2015).
-
(2015)
BMJ Open Gastroenterol
, vol.2
, pp. e000019
-
-
Wood, K.L.1
Miller, M.H.2
Dillon, J.F.3
-
30
-
-
56749096610
-
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
-
S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, L. A. Pennacchio, E. Boerwinkle, J. C. Cohen, H. H. Hobbs, Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461-1465 (2008).
-
(2008)
Nat. Genet
, vol.40
, pp. 1461-1465
-
-
Romeo, S.1
Kozlitina, J.2
Xing, C.3
Pertsemlidis, A.4
Cox, D.5
Pennacchio, L.A.6
Boerwinkle, E.7
Cohen, J.C.8
Hobbs, H.H.9
-
31
-
-
70350550096
-
Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene
-
K. Kantartzis, A. Peter, F. Machicao, J. Machann, S. Wagner, I. Konigsrainer, A. Königsrainer, F. Schick, A. Fritsche, H.-U. Haring, N. Stefan, Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58, 2616-2623 (2009).
-
(2009)
Diabetes
, vol.58
, pp. 2616-2623
-
-
Kantartzis, K.1
Peter, A.2
Machicao, F.3
Machann, J.4
Wagner, S.5
Konigsrainer, I.6
Königsrainer, A.7
Schick, F.8
Fritsche, A.9
Haring, H.-U.10
Stefan, N.11
-
32
-
-
67349174005
-
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
-
A. Kotronen, L. E. Johansson, L. M. Johansson, C. Roos, J. Westerbacka, A. Hamsten, R. Bergholm, P. Arkkila, J. Arola, T. Kiviluoto, R. M. Fisher, E. Ehrenborg, M. Orho-Melander, M. Ridderstrale, L. Groop, H. Yki-Järvinen, A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans. Diabetologia 52, 1056-1060 (2009).
-
(2009)
Diabetologia
, vol.52
, pp. 1056-1060
-
-
Kotronen, A.1
Johansson, L.E.2
Johansson, L.M.3
Roos, C.4
Westerbacka, J.5
Hamsten, A.6
Bergholm, R.7
Arkkila, P.8
Arola, J.9
Kiviluoto, T.10
Fisher, R.M.11
Ehrenborg, E.12
Orho-Melander, M.13
Ridderstrale, M.14
Groop, L.15
Yki-Järvinen, H.16
-
33
-
-
77956630787
-
PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease
-
E. K. Speliotes, J. L. Butler, C. D. Palmer, B. F. Voight; GIANT Consortium, MIGen Consortium, NASH CRN, J. N. Hirschhorn, PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease. Hepatology 52, 904-912 (2010).
-
(2010)
Hepatology
, vol.52
, pp. 904-912
-
-
Speliotes, E.K.1
Butler, J.L.2
Palmer, C.D.3
Voight, B.F.4
Consortium, G.5
Consortium, M.6
Crn, N.7
Hirschhorn, J.N.8
-
34
-
-
78751536418
-
Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians
-
F. Stickel, S. Buch, K. Lau, H. Meyer zu Schwabedissen, T. Berg, M. Ridinger, M. Rietschel, C. Schafmayer, F. Braun, H. Hinrichsen, R. Günther, A. Arlt, M. Seeger, S. Müller, H. K. Seitz, M. Soyka, M. Lerch, F. Lammert, C. Sarrazin, R. Kubitz, D. Häussinger, C. Hellerbrand, D. Bröring, S. Schreiber, F. Kiefer, R. Spanagel, K. Mann, C. Datz, M. Krawczak, N. Wodarz, H. Völzke, J. Hampe, Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians. Hepatology 53, 86-95 (2011).
-
(2011)
Hepatology
, vol.53
, pp. 86-95
-
-
Stickel, F.1
Buch, S.2
Lau, K.3
Meyer Zu Schwabedissen, H.4
Berg, T.5
Ridinger, M.6
Rietschel, M.7
Schafmayer, C.8
Braun, F.9
Hinrichsen, H.10
Günther, R.11
Arlt, A.12
Seeger, M.13
Müller, S.14
Seitz, H.K.15
Soyka, M.16
Lerch, M.17
Lammert, F.18
Sarrazin, C.19
Kubitz, R.20
Häussinger, D.21
Hellerbrand, C.22
Bröring, D.23
Schreiber, S.24
Kiefer, F.25
Spanagel, R.26
Mann, K.27
Datz, C.28
Krawczak, M.29
Wodarz, N.30
Völzke, H.31
Hampe, J.32
more..
-
35
-
-
78651328101
-
Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption
-
J. N. Davis, K.-A. Lê, R. W. Walker, S. Vikman, D. Spruijt-Metz, M. J. Weigensberg, H. Allayee, M. I. Goran, Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption. Am. J. Clin. Nutr. 92, 1522-1527 (2010).
-
(2010)
Am. J. Clin. Nutr
, vol.92
, pp. 1522-1527
-
-
Davis, J.N.1
Lê, K.-A.2
Walker, R.W.3
Vikman, S.4
Spruijt-Metz, D.5
Weigensberg, M.J.6
Allayee, H.7
Goran, M.I.8
-
36
-
-
49449098216
-
Dietary fructose consumption among US children and adults: The Third National Health and Nutrition Examination Survey. Medscape
-
M. B. Vos, J. E. Kimmons, C. Gillespie, J. Welsh, H. M. Blanck, Dietary fructose consumption among US children and adults: The Third National Health and Nutrition Examination Survey. Medscape J. Med. 10, 160 (2008).
-
(2008)
J. Med
, vol.10
, pp. 160
-
-
Vos, M.B.1
Kimmons, J.E.2
Gillespie, C.3
Welsh, J.4
Blanck, H.M.5
-
37
-
-
77949895032
-
A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis
-
S. He, C. McPhaul, J. Z. Li, R. Garuti, L. Kinch, N. V. Grishin, J. C. Cohen, H. H. Hobbs, A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J. Biol. Chem. 285, 6706-6715 (2010).
-
(2010)
J. Biol. Chem
, vol.285
, pp. 6706-6715
-
-
He, S.1
McPhaul, C.2
Li, J.Z.3
Garuti, R.4
Kinch, L.5
Grishin, N.V.6
Cohen, J.C.7
Hobbs, H.H.8
-
38
-
-
84860465005
-
Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase
-
M. Kumari, G. Schoiswohl, C. Chitraju, M. Paar, I. Cornaciu, A. Y. Rangrez, N. Wongsiriroj, H. M. Nagy, P. T. Ivanova, S. A. Scott, O. Knittelfelder, G. N. Rechberger, R. Birner-Gruenberger, S. Eder, H. A. Brown, G. Haemmerle, M. Oberer, A. Lass, E. E. Kershaw, R. Zimmermann, R. Zechner, Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase. Cell Metab. 15, 691-702 (2012).
-
(2012)
Cell Metab
, vol.15
, pp. 691-702
-
-
Kumari, M.1
Schoiswohl, G.2
Chitraju, C.3
Paar, M.4
Cornaciu, I.5
Rangrez, A.Y.6
Wongsiriroj, N.7
Nagy, H.M.8
Ivanova, P.T.9
Scott, S.A.10
Knittelfelder, O.11
Rechberger, G.N.12
Birner-Gruenberger, R.13
Eder, S.14
Brown, H.A.15
Haemmerle, G.16
Oberer, M.17
Lass, A.18
Kershaw, E.E.19
Zimmermann, R.20
Zechner, R.21
more..
-
39
-
-
84891810442
-
Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity
-
J. Hyysalo, P. Gopalacharyulu, H. Bian, T. Hyötyläinen, M. Leivonen, N. Jaser, A. Juuti, M.-J. Honka, P. Nuutila, V. M. Olkkonen, M. Oresic, H. Yki-Järvinen, Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity. Diabetes 63, 312-322 (2014).
-
(2014)
Diabetes
, vol.63
, pp. 312-322
-
-
Hyysalo, J.1
Gopalacharyulu, P.2
Bian, H.3
Hyötyläinen, T.4
Leivonen, M.5
Jaser, N.6
Juuti, A.7
Honka, M.-J.8
Nuutila, P.9
Olkkonen, V.M.10
Oresic, M.11
Yki-Järvinen, H.12
-
40
-
-
84898058711
-
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
-
J. Kozlitina, E. Smagris, S. Stender, B. G. Nordestgaard, H. H. Zhou, A. Tybjærg-Hansen, T. F. Vogt, H. H. Hobbs, J. C. Cohen, Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 46, 352-356 (2014).
-
(2014)
Nat. Genet
, vol.46
, pp. 352-356
-
-
Kozlitina, J.1
Smagris, E.2
Stender, S.3
Nordestgaard, B.G.4
Zhou, H.H.5
Tybjærg-Hansen, A.6
Vogt, T.F.7
Hobbs, H.H.8
Cohen, J.C.9
-
41
-
-
84921487729
-
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
-
P. Dongiovanni, S. Petta, C. Maglio, A. L. Fracanzani, R. Pipitone, E. Mozzi, B. M. Motta, D. Kaminska, R. Rametta, S. Grimaudo, S. Pelusi, T. Montalcini, A. Alisi, M. Maggioni, V. Kärjä, J. Borén, P. Käkelä, V. Di Marco, C. Xing, V. Nobili, B. Dallapiccola, A. Craxi, J. Pihlajamäki, S. Fargion, L. Sjöström, L. M. Carlsson, S. Romeo, L. Valenti, Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease. Hepatology 61, 506-514 (2015).
-
(2015)
Hepatology
, vol.61
, pp. 506-514
-
-
Dongiovanni, P.1
Petta, S.2
Maglio, C.3
Fracanzani, A.L.4
Pipitone, R.5
Mozzi, E.6
Motta, B.M.7
Kaminska, D.8
Rametta, R.9
Grimaudo, S.10
Pelusi, S.11
Montalcini, T.12
Alisi, A.13
Maggioni, M.14
Kärjä, V.15
Borén, J.16
Käkelä, P.17
Di Marco, V.18
Xing, C.19
Nobili, V.20
Dallapiccola, B.21
Craxi, A.22
Pihlajamäki, J.23
Fargion, S.24
Sjöström, L.25
Carlsson, L.M.26
Romeo, S.27
Valenti, L.28
more..
-
42
-
-
84898058547
-
Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
-
O. L. Holmen, H. Zhang, Y. Fan, D. H. Hovelson, E. M. Schmidt, W. Zhou, Y. Guo, J. Zhang, A. Langhammer, M.-L. Løchen, S. K. Ganesh, L. Vatten, F. Skorpen, H. Dalen, J. Zhang, S. Pennathur, J. Chen, C. Platou, E. B. Mathiesen, T. Wilsgaard, I. Njølstad, M. Boehnke, Y. E. Chen, G. R. Abecasis, K. Hveem, C. J. Willer, Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk. Nat. Genet. 46, 345-351 (2014).
-
(2014)
Nat. Genet
, vol.46
, pp. 345-351
-
-
Holmen, O.L.1
Zhang, H.2
Fan, Y.3
Hovelson, D.H.4
Schmidt, E.M.5
Zhou, W.6
Guo, Y.7
Zhang, J.8
Langhammer, A.9
Løchen, M.-L.10
Ganesh, S.K.11
Vatten, L.12
Skorpen, F.13
Dalen, H.14
Zhang, J.15
Pennathur, S.16
Chen, J.17
Platou, C.18
Mathiesen, E.B.19
Wilsgaard, T.20
Njølstad, I.21
Boehnke, M.22
Chen, Y.E.23
Abecasis, G.R.24
Hveem, K.25
Willer, C.J.26
more..
-
43
-
-
84924938800
-
Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and metaanalysis of paired-biopsy studies
-
e1-9
-
S. Singh, A. M. Allen, Z. Wang, L. J. Prokop, M. H. Murad, R. Loomba, Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: A systematic review and metaanalysis of paired-biopsy studies. Clin. Gastroenterol. Hepatol. 13, 643-654.e1-9 (2015).
-
(2015)
Clin. Gastroenterol. Hepatol
, vol.13
, pp. 643-654
-
-
Singh, S.1
Allen, A.M.2
Wang, Z.3
Prokop, L.J.4
Murad, M.H.5
Loomba, R.6
-
44
-
-
84937522314
-
Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis
-
A. Arulanandan, B. Ang, R. Bettencourt, J. Hooker, C. Behling, G. Y. Lin, M. A. Valasek, J. H. Ix, B. Schnabl, C. B. Sirlin, R. Loomba, Association between quantity of liver fat and cardiovascular risk in patients with nonalcoholic fatty liver disease independent of nonalcoholic steatohepatitis. Clin. Gastroenterol. Hepatol. 13, 1513-1520.e1 (2015).
-
(2015)
Clin. Gastroenterol. Hepatol
, vol.13
, pp. 1513-1513e1
-
-
Arulanandan, A.1
Ang, B.2
Bettencourt, R.3
Hooker, J.4
Behling, C.5
Lin, G.Y.6
Valasek, M.A.7
Ix, J.H.8
Schnabl, B.9
Sirlin, C.B.10
Loomba, R.11
-
45
-
-
84929166661
-
Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents
-
R. Jin, N.-A. Le, R. Cleeton, X. Sun, J. Cruz Muños, J. Otvos, M. B. Vos, Amount of hepatic fat predicts cardiovascular risk independent of insulin resistance among Hispanic-American adolescents. Lipids Health Dis. 14, 39 (2015).
-
(2015)
Lipids Health Dis
, vol.14
, pp. 39
-
-
Jin, R.1
Le, N.-A.2
Cleeton, R.3
Sun, X.4
Cruz Muños, J.5
Otvos, J.6
Vos, M.B.7
-
46
-
-
84889658153
-
Cohort study of non-alcoholic fatty liver disease NAFLD fibrosis score, and the risk of incident diabetes in a Korean population
-
Y. Chang, H.-S. Jung, K. E. Yun, J. Cho, Y. K. Cho, S. Ryu, Cohort study of non-alcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. Am. J. Gastroenterol. 108, 1861-1868 (2013).
-
(2013)
Am. J. Gastroenterol
, vol.108
, pp. 1861-1868
-
-
Chang, Y.1
Jung, H.-S.2
Yun, K.E.3
Cho, J.4
Cho, Y.K.5
Ryu, S.6
-
47
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
D. E. Kleiner, E. M. Brunt, M. Van Natta, C. Behling, M. J. Contos, O. W. Cummings, L. D. Ferrell, Y.-C. Liu, M. S. Torbenson, A. Unalp-Arida, M. Yeh, A. J.McCullough, A. J. Sanyal, Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321 (2005).
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
Behling, C.4
Contos, M.J.5
Cummings, O.W.6
Ferrell, L.D.7
Liu, Y.-C.8
Torbenson, M.S.9
Unalp-Arida, A.10
Yeh, M.11
McCullough, A.J.12
Sanyal, A.J.13
-
48
-
-
34548337060
-
Histological progression of non-alcoholic fatty liver disease: A critical reassessment based on liver sampling variability
-
V. Ratziu, E. Bugianesi, J. Dixon, E. Fassio, M. Ekstedt, F. Charlotte, S. Kechagias, T. Poynard, R. Olsson, Histological progression of non-alcoholic fatty liver disease: A critical reassessment based on liver sampling variability. Aliment. Pharmacol. Ther. 26, 821-830 (2007).
-
(2007)
Aliment. Pharmacol. Ther
, vol.26
, pp. 821-830
-
-
Ratziu, V.1
Bugianesi, E.2
Dixon, J.3
Fassio, E.4
Ekstedt, M.5
Charlotte, F.6
Kechagias, S.7
Poynard, T.8
Olsson, R.9
-
49
-
-
0037566201
-
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
-
P. Mofrad, M. J. Contos, M. Haque, C. Sargeant, R. A. Fisher, V. A. Luketic, R. K. Sterling, M. L. Shiffman, R. T. Stravitz, A. J. Sanyal, Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 37, 1286-1292 (2003).
-
(2003)
Hepatology
, vol.37
, pp. 1286-1292
-
-
Mofrad, P.1
Contos, M.J.2
Haque, M.3
Sargeant, C.4
Fisher, R.A.5
Luketic, V.A.6
Sterling, R.K.7
Shiffman, M.L.8
Stravitz, R.T.9
Sanyal, A.J.10
-
50
-
-
84865517060
-
Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects
-
W.-C. Wu, C.-Y. Wu, Y.-J. Wang, H.-H. Hung, H.-I. Yang, W.-Y. Kao, C.-W. Su, J.-C. Wu, W.-L. Chan, H.-C. Lin, F.-Y. Lee, S.-D. Lee, Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects. Aliment. Pharmacol. Ther. 36, 560-568 (2012).
-
(2012)
Aliment. Pharmacol. Ther
, vol.36
, pp. 560-568
-
-
Wu, W.-C.1
Wu, C.-Y.2
Wang, Y.-J.3
Hung, H.-H.4
Yang, H.-I.5
Kao, W.-Y.6
Su, C.-W.7
Wu, J.-C.8
Chan, W.-L.9
Lin, H.-C.10
Lee, F.-Y.11
Lee, S.-D.12
-
51
-
-
77949816251
-
SAFETY study: Alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease
-
e1-2
-
J. B. Schwimmer, W. Dunn, G. J. Norman, P. E. Pardee, M. S. Middleton, N. Kerkar, C. B. Sirlin, SAFETY study: Alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 138, 1357-1364.e1-2 (2010).
-
(2010)
Gastroenterology
, vol.138
, pp. 1357-1364
-
-
Schwimmer, J.B.1
Dunn, W.2
Norman, G.J.3
Pardee, P.E.4
Middleton, M.S.5
Kerkar, N.6
Sirlin, C.B.7
-
52
-
-
79961203306
-
Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD
-
A. Shannon, N. Alkhouri, C. Carter-Kent, L. Monti, R. Devito, R. Lopez, A. E. Feldstein, V. Nobili, Ultrasonographic quantitative estimation of hepatic steatosis in children with NAFLD. J. Pediatr. Gastroenterol. Nutr. 53, 190-195 (2011).
-
(2011)
J. Pediatr. Gastroenterol. Nutr.
, vol.53
, pp. 190-195
-
-
Shannon, A.1
Alkhouri, N.2
Carter-Kent, C.3
Monti, L.4
Devito, R.5
Lopez, R.6
Feldstein, A.E.7
Nobili, V.8
-
53
-
-
0036729447
-
The utility of radiological imaging in nonalcoholic fatty liver disease
-
S. Saadeh, Z. M. Younossi, E. M. Remer, T. Gramlich, J. P. Ong, M. Hurley, K. D. Mullen, J. N. Cooper, M. J. Sheridan, The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745-750 (2002).
-
(2002)
Gastroenterology
, vol.123
, pp. 745-750
-
-
Saadeh, S.1
Younossi, Z.M.2
Remer, E.M.3
Gramlich, T.4
Ong, J.P.5
Hurley, M.6
Mullen, K.D.7
Cooper, J.N.8
Sheridan, M.J.9
-
54
-
-
71849092184
-
Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
-
S. Dasarathy, J. Dasarathy, A. Khiyami, R. Joseph, R. Lopez, A. J. McCullough, Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study. J. Hepatol. 51, 1061-1067 (2009).
-
(2009)
J. Hepatol
, vol.51
, pp. 1061-1067
-
-
Dasarathy, S.1
Dasarathy, J.2
Khiyami, A.3
Joseph, R.4
Lopez, R.5
McCullough, A.J.6
-
55
-
-
84931574623
-
Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique
-
S. C. Lin, E. Heba, T. Wolfson, B. Ang, A. Gamst, A. Han, J. W. Erdman Jr., W. D. O'Brien Jr., M. P. Andre, C. B. Sirlin, R. Loomba, Noninvasive diagnosis of nonalcoholic fatty liver disease and quantification of liver fat using a new quantitative ultrasound technique. Clin. Gastroenterol. Hepatol. 13, 1337-1345.e6 (2015).
-
(2015)
Clin. Gastroenterol. Hepatol
, vol.13
, pp. 1337-1345e6
-
-
Lin, S.C.1
Heba, E.2
Wolfson, T.3
Ang, B.4
Gamst, A.5
Han, A.6
Erdman, J.W.7
O'Brien, W.D.8
Andre, M.P.9
Sirlin, C.B.10
Loomba, R.11
-
56
-
-
84856708238
-
The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan
-
M. Sasso, V. Miette, L. Sandrin, M. Beaugrand, The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin. Res. Hepatol. Gastroenterol. 36, 13-20 (2012).
-
(2012)
Clin. Res. Hepatol. Gastroenterol
, vol.36
, pp. 13-20
-
-
Sasso, M.1
Miette, V.2
Sandrin, L.3
Beaugrand, M.4
-
57
-
-
77958154016
-
Controlled attenuation parameter (CAP): A novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes
-
M. Sasso, M. Beaugrand, V. de Ledinghen, C. Douvin, P. Marcellin, R. Poupon, L. Sandrin, V. Miette, Controlled attenuation parameter (CAP): A novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med. Biol. 36, 1825-1835 (2010).
-
(2010)
Ultrasound Med. Biol
, vol.36
, pp. 1825-1835
-
-
Sasso, M.1
Beaugrand, M.2
De Ledinghen, V.3
Douvin, C.4
Marcellin, P.5
Poupon, R.6
Sandrin, L.7
Miette, V.8
-
58
-
-
84876907610
-
Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis
-
A. Tang, J. Tan, M. Sun, G. Hamilton, M. Bydder, T. Wolfson, A. C. Gamst, M. Middleton, E. M. Brunt, R. Loomba, J. E. Lavine, J. B. Schwimmer, C. B. Sirlin, Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267, 422-431 (2013).
-
(2013)
Radiology
, vol.267
, pp. 422-431
-
-
Tang, A.1
Tan, J.2
Sun, M.3
Hamilton, G.4
Bydder, M.5
Wolfson, T.6
Gamst, A.C.7
Middleton, M.8
Brunt, E.M.9
Loomba, R.10
Lavine, J.E.11
Schwimmer, J.B.12
Sirlin, C.B.13
-
59
-
-
84929607638
-
Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease
-
J. B. Schwimmer, M. S. Middleton, C. Behling, K. P. Newton, H. I. Awai, M. N. Paiz, J. Lam, J. C. Hooker, G. Hamilton, J. Fontanesi, C. B. Sirlin, Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease. Hepatology 61, 1887-1895 (2015).
-
(2015)
Hepatology
, vol.61
, pp. 1887-1895
-
-
Schwimmer, J.B.1
Middleton, M.S.2
Behling, C.3
Newton, K.P.4
Awai, H.I.5
Paiz, M.N.6
Lam, J.7
Hooker, J.C.8
Hamilton, G.9
Fontanesi, J.10
Sirlin, C.B.11
-
60
-
-
33745904468
-
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
-
A. Wieckowska, N. N. Zein, L. M. Yerian, A. R. Lopez, A. J. McCullough, A. E. Feldstein, In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44, 27-33 (2006).
-
(2006)
Hepatology
, vol.44
, pp. 27-33
-
-
Wieckowska, A.1
Zein, N.N.2
Yerian, L.M.3
Lopez, A.R.4
McCullough, A.J.5
Feldstein, A.E.6
-
61
-
-
70350046669
-
Cytokeratin- 18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
-
A. E. Feldstein, A. Wieckowska, A. R. Lopez, Y.-C. Liu, N. N. Zein, A. J. McCullough, Cytokeratin- 18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study. Hepatology 50, 1072-1078 (2009).
-
(2009)
Hepatology
, vol.50
, pp. 1072-1078
-
-
Feldstein, A.E.1
Wieckowska, A.2
Lopez, A.R.3
Liu, Y.-C.4
Zein, N.N.5
McCullough, A.J.6
-
62
-
-
79956108335
-
An apoptosis panel for nonalcoholic steatohepatitis diagnosis
-
T. I. Abu-Rajab Tamimi, H. M. Elgouhari, N. Alkhouri, L. M. Yerian, M. P. Berk, R. Lopez, P. R. Schauer, N. N. Zein, A. E. Feldstein, An apoptosis panel for nonalcoholic steatohepatitis diagnosis. J. Hepatol. 54, 1224-1229 (2011).
-
(2011)
J. Hepatol
, vol.54
, pp. 1224-1229
-
-
Abu-Rajab Tamimi, T.I.1
Elgouhari, H.M.2
Alkhouri, N.3
Yerian, L.M.4
Berk, M.P.5
Lopez, R.6
Schauer, P.R.7
Zein, N.N.8
Feldstein, A.E.9
-
63
-
-
84862795311
-
Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers
-
J. Shen, H. L.-Y. Chan, G. L.-H. Wong, P. C.-L. Choi, A. W.-H. Chan, H.-Y. Chan, A. M.-L. Chim, D. K.-W. Yeung, F. K.-L. Chan, J. Woo, J. Yu, W. C.-W. Chu, V. W.-S.Wong, Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J. Hepatol. 56, 1363-1370 (2012).
-
(2012)
J. Hepatol
, vol.56
, pp. 1363-1370
-
-
Shen, J.1
Chan, H.L.-Y.2
Wong, G.L.-H.3
Choi, P.C.-L.4
Chan, A.W.-H.5
Chan, H.-Y.6
Chim, A.M.-L.7
Yeung, D.K.-W.8
Chan, F.K.-L.9
Woo, J.10
Yu, J.11
Chu, W.C.-W.12
Wong, V.W.-S.13
-
64
-
-
84890547086
-
Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease
-
K. Cusi, Z. Chang, S. Harrison, R. Lomonaco, F. Bril, B. Orsak, C. Ortiz-Lopez, J. Hecht, A. E. Feldstein, A. Webb, C. Louden, M. Goros, F. Tio, Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. J. Hepatol. 60, 167-174 (2014).
-
(2014)
J. Hepatol
, vol.60
, pp. 167-174
-
-
Cusi, K.1
Chang, Z.2
Harrison, S.3
Lomonaco, R.4
Bril, F.5
Orsak, B.6
Ortiz-Lopez, C.7
Hecht, J.8
Feldstein, A.E.9
Webb, A.10
Louden, C.11
Goros, M.12
Tio, F.13
-
65
-
-
84918770626
-
Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease
-
e1-2
-
R. Vuppalanchi, A. K. Jain, R. Deppe, K. Yates, M. Comerford, H. C. Masuoka, B. A. Neuschwander-Tetri, R. Loomba, E. M. Brunt, D. E. Kleiner, J. P.Molleston, J. B. Schwimmer, J. E. Lavine, J. Tonascia, N. Chalasani, Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 12, 2121-2130.e1-2 (2014).
-
(2014)
Clin. Gastroenterol. Hepatol
, vol.12
, pp. 2121-2130
-
-
Vuppalanchi, R.1
Jain, A.K.2
Deppe, R.3
Yates, K.4
Comerford, M.5
Masuoka, H.C.6
Neuschwander-Tetri, B.A.7
Loomba, R.8
Brunt, E.M.9
Kleiner, D.E.10
Molleston, J.P.11
Schwimmer, J.B.12
Lavine, J.E.13
Tonascia, J.14
Chalasani, N.15
-
66
-
-
84901660263
-
Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: A proof-of-concept study
-
N. Bastati, D. Feier, A. Wibmer, S. Traussnigg, C. Balassy, D. Tamandl, H. Einspieler, F. Wrba, M. Trauner, C. Herold, A. Ba-Ssalamah, Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: A proof-of-concept study. Radiology 271, 739-747 (2014).
-
(2014)
Radiology
, vol.271
, pp. 739-747
-
-
Bastati, N.1
Feier, D.2
Wibmer, A.3
Traussnigg, S.4
Balassy, C.5
Tamandl, D.6
Einspieler, H.7
Wrba, F.8
Trauner, M.9
Herold, C.10
Ba-Ssalamah, A.11
-
67
-
-
84938057875
-
Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease
-
P. Angulo, D. E. Kleiner, S. Dam-Larsen, L. A. Adams, E. S. Bjornsson, P. Charatcharoenwitthaya, P. R. Mills, J. C. Keach, H. D. Lafferty, A. Stahler, S. Haflidadottir, F. Bendtsen, Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149, 389-397.e10 (2015).
-
(2015)
Gastroenterology
, vol.149
, pp. 389-389e10
-
-
Angulo, P.1
Kleiner, D.E.2
Dam-Larsen, S.3
Adams, L.A.4
Bjornsson, E.S.5
Charatcharoenwitthaya, P.6
Mills, P.R.7
Keach, J.C.8
Lafferty, H.D.9
Stahler, A.10
Haflidadottir, S.11
Bendtsen, F.12
-
68
-
-
84929289615
-
Comparative diagnostic accuracy of magnetic resonance elastography vs. Eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: A prospective study
-
J. Cui, B. Ang, W. Haufe, C. Hernandez, E. C. Verna, C. B. Sirlin, R. Loomba, Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: A prospective study. Aliment. Pharmacol. Ther. 41, 1271-1280 (2015).
-
(2015)
Aliment. Pharmacol. Ther
, vol.41
, pp. 1271-1280
-
-
Cui, J.1
Ang, B.2
Haufe, W.3
Hernandez, C.4
Verna, E.C.5
Sirlin, C.B.6
Loomba, R.7
-
69
-
-
9144249563
-
Transient elastography: A new noninvasive method for assessment of hepatic fibrosis
-
L. Sandrin, B. Fourquet, J.-M. Hasquenoph, S. Yon, C. Fournier, F. Mal, C. Christidis, M. Ziol, B. Poulet, F. Kazemi, M. Beaugrand, R. Palau, Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 29, 1705-1713 (2003).
-
(2003)
Ultrasound Med. Biol
, vol.29
, pp. 1705-1713
-
-
Sandrin, L.1
Fourquet, B.2
Hasquenoph, J.-M.3
Yon, S.4
Fournier, C.5
Mal, F.6
Christidis, C.7
Ziol, M.8
Poulet, B.9
Kazemi, F.10
Beaugrand, M.11
Palau, R.12
-
70
-
-
84891889855
-
Systematic review with meta-analysis: Non-invasive assessment of non-alcoholic fatty liver disease - The role of transient elastography and plasma cytokeratin-18 fragments
-
R. Kwok, Y.-K. Tse, G. L.-H. Wong, Y. Ha, A. U. Lee, M. C. Ngu, H. L.-Y. Chan, V. W.-S. Wong, Systematic review with meta-analysis: Non-invasive assessment of non-alcoholic fatty liver disease - The role of transient elastography and plasma cytokeratin-18 fragments. Aliment. Pharmacol. Ther. 39, 254-269 (2014).
-
(2014)
Aliment. Pharmacol. Ther
, vol.39
, pp. 254-269
-
-
Kwok, R.1
Tse, Y.-K.2
Wong, G.L.-H.3
Ha, Y.4
Lee, A.U.5
Ngu, M.C.6
Chan, H.L.-Y.7
Wong, V.W.-S.8
-
71
-
-
77950619459
-
Pitfalls of liver stiffness measurement: A 5-year prospective study of 13, 369 examinations
-
L. Castéra, J. Foucher, P.-H. Bernard, F. Carvalho, D. Allaix, W. Merrouche, P. Couzigou, V. de Lédinghen, Pitfalls of liver stiffness measurement: A 5-year prospective study of 13, 369 examinations. Hepatology 51, 828-835 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 828-835
-
-
Castéra, L.1
Foucher, J.2
Bernard, P.-H.3
Carvalho, F.4
Allaix, D.5
Merrouche, W.6
Couzigou, P.7
De Lédinghen, V.8
-
72
-
-
84929354082
-
Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis
-
E. Vilar-Gomez, Y. Martinez-Perez, L. Calzadilla-Bertot, A. Torres-Gonzalez, B. Gra-Oramas, L. Gonzalez-Fabian, S. L. Friedman, M. Diago, M. Romero-Gomez, Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology 149, 367-378.e5 (2015).
-
(2015)
Gastroenterology
, vol.149
, pp. 367-378e5
-
-
Vilar-Gomez, E.1
Martinez-Perez, Y.2
Calzadilla-Bertot, L.3
Torres-Gonzalez, A.4
Gra-Oramas, B.5
Gonzalez-Fabian, L.6
Friedman, S.L.7
Diago, M.8
Romero-Gomez, M.9
-
73
-
-
73449116035
-
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
-
K. Promrat, D. E. Kleiner, H. M. Niemeier, E. Jackvony, M. Kearns, J. R. Wands, J. L. Fava, R. R. Wing, Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51, 121-129 (2010).
-
(2010)
Hepatology
, vol.51
, pp. 121-129
-
-
Promrat, K.1
Kleiner, D.E.2
Niemeier, H.M.3
Jackvony, E.4
Kearns, M.5
Wands, J.R.6
Fava, J.L.7
Wing, R.R.8
-
74
-
-
84855346047
-
Correlation of Vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD
-
NASH CRN Research Group
-
M. B. Vos, R. Colvin, P. Belt, J. P. Molleston, K. F. Murray, P. Rosenthal, J. B. Schwimmer, J. Tonascia, A. Unalp, J. E. Lavine; NASH CRN Research Group, Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD. J. Pediatr. Gastroenterol. Nutr. 54, 90-96 (2012).
-
(2012)
J. Pediatr. Gastroenterol. Nutr
, vol.54
, pp. 90-96
-
-
Vos, M.B.1
Colvin, R.2
Belt, P.3
Molleston, J.P.4
Murray, K.F.5
Rosenthal, P.6
Schwimmer, J.B.7
Tonascia, J.8
Unalp, A.9
Lavine, J.E.10
-
75
-
-
0029849462
-
Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects
-
G. Perseghin, T. B. Price, K. F. Petersen, M. Roden, G. W. Cline, K. Gerow, D. L. Rothman, G. I. Shulman, Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. N. Engl. J. Med. 335, 1357-1362 (1996).
-
(1996)
N. Engl. J. Med
, vol.335
, pp. 1357-1362
-
-
Perseghin, G.1
Price, T.B.2
Petersen, K.F.3
Roden, M.4
Cline, G.W.5
Gerow, K.6
Rothman, D.L.7
Shulman, G.I.8
-
76
-
-
80051971972
-
Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals
-
R. Rabøl, K. F. Petersen, S. Dufour, C. Flannery, G. I. Shulman, Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals. Proc. Natl. Acad. Sci. U.S.A. 108, 13705-13709 (2011).
-
(2011)
Proc. Natl. Acad. Sci. U.S.A
, vol.108
, pp. 13705-13709
-
-
Rabøl, R.1
Petersen, K.F.2
Dufour, S.3
Flannery, C.4
Shulman, G.I.5
-
78
-
-
84930654328
-
Current efforts and trends in the treatment of NASH
-
V. Ratziu, Z. Goodman, A. Sanyal, Current efforts and trends in the treatment of NASH. J. Hepatol. 62, S65-S75 (2015).
-
(2015)
J. Hepatol
, vol.62
, pp. S65-S75
-
-
Ratziu, V.1
Goodman, Z.2
Sanyal, A.3
-
79
-
-
77951874018
-
Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis
-
A. J. Sanyal, N. Chalasani, K. V. Kowdley, A. McCullough, A. M. Diehl, N. M. Bass, B. A. Neuschwander-Tetri, J. E. Lavine, J. Tonascia, A. Unalp, M. Van Natta, J. Clark, E. M. Brunt, D. E. Kleiner, J. H. Hoofnagle, P. R. Robuck; NASH CRN, Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675-1685 (2010).
-
(2010)
N. Engl. J. Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
McCullough, A.4
Diehl, A.M.5
Bass, N.M.6
Neuschwander-Tetri, B.A.7
Lavine, J.E.8
Tonascia, J.9
Unalp, A.10
Van Natta, M.11
Clark, J.12
Brunt, E.M.13
Kleiner, D.E.14
Hoofnagle, J.H.15
Robuck, P.R.16
Crn, N.17
-
80
-
-
84908362139
-
Review article: The management of paediatric nonalcoholic fatty liver disease
-
E. B. Mitchel, J. E. Lavine, Review article: The management of paediatric nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 40, 1155-1170 (2014).
-
(2014)
Aliment. Pharmacol. Ther
, vol.40
, pp. 1155-1170
-
-
Mitchel, E.B.1
Lavine, J.E.2
-
81
-
-
78249262957
-
Meta-analysis: Insulin sensitizers for the treatment of non-alcoholic steatohepatitis
-
M. O. Rakoski, A. G. Singal, M. A. M. Rogers, H. Conjeevaram, Meta-analysis: Insulin sensitizers for the treatment of non-alcoholic steatohepatitis. Aliment. Pharmacol. Ther. 32, 1211-1221 (2010).
-
(2010)
Aliment. Pharmacol. Ther
, vol.32
, pp. 1211-1221
-
-
Rakoski, M.O.1
Singal, A.G.2
Rogers, M.A.M.3
Conjeevaram, H.4
-
82
-
-
79955446251
-
Effect of Vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial
-
Nonalcoholic Steatohepatitis Clinical Research Network
-
J. E. Lavine, J. B. Schwimmer, M. L. Van Natta, J. P. Molleston, K. F. Murray, P. Rosenthal, S. H. Abrams, A. O. Scheimann, A. J. Sanyal, N. Chalasani, J. Tonascia, A. Ünalp, J. M. Clark, E. M. Brunt, D. E. Kleiner, J. H. Hoofnagle, P. R. Robuck; Nonalcoholic Steatohepatitis Clinical Research Network, Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: The TONIC randomized controlled trial. JAMA 305, 1659-1668 (2011).
-
(2011)
JAMA
, vol.305
, pp. 1659-1668
-
-
Lavine, J.E.1
Schwimmer, J.B.2
Van Natta, M.L.3
Molleston, J.P.4
Murray, K.F.5
Rosenthal, P.6
Abrams, S.H.7
Scheimann, A.O.8
Sanyal, A.J.9
Chalasani, N.10
Tonascia, J.11
Ünalp, A.12
Clark, J.M.13
Brunt, E.M.14
Kleiner, D.E.15
Hoofnagle, J.H.16
Robuck, P.R.17
-
83
-
-
39649101196
-
Activation of peroxisome proliferator-activated receptor (PPAR)d promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men
-
U. Risérus, D. Sprecher, T. Johnson, E. Olson, S. Hirschberg, A. Liu, Z. Fang, P. Hegde, D. Richards, L. Sarov-Blat, J. C. Strum, S. Basu, J. Cheeseman, B. A. Fielding, S. M. Humphreys, T. Danoff, N. R. Moore, P. Murgatroyd, S. O'Rahilly, P. Sutton, T. Willson, D. Hassall, K. N. Frayn, F. Karpe, Activation of peroxisome proliferator-activated receptor (PPAR)d promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes 57, 332-339 (2008).
-
(2008)
Diabetes
, vol.57
, pp. 332-339
-
-
Risérus, U.1
Sprecher, D.2
Johnson, T.3
Olson, E.4
Hirschberg, S.5
Liu, A.6
Fang, Z.7
Hegde, P.8
Richards, D.9
Sarov-Blat, L.10
Strum, J.C.11
Basu, S.12
Cheeseman, J.13
Fielding, B.A.14
Humphreys, S.M.15
Danoff, T.16
Moore, N.R.17
Murgatroyd, P.18
O'Rahilly, S.19
Sutton, P.20
Willson, T.21
Hassall, D.22
Frayn, K.N.23
Karpe, F.24
more..
-
84
-
-
84970924272
-
An international, phase 2 randomized controlled trial of the dual PPAR a-d agonist GFT505 in adult patients with NASH
-
San Francisco, CA 16 November
-
V. Ratziu, S. A. Harrison, S. M. Francque, P. Bedossa, L. Serfaty, M. Romero-Gomez, P. Cales, M. F. Abdelmalek, S. H. Caldwell, J. Drenth, Q. M. Anstee, D. W. Hum, R. Hanf, A. Roudot, S. Megnien, B. Staels, A. Sanyal, An international, phase 2 randomized controlled trial of the dual PPAR a-d agonist GFT505 in adult patients with NASH, The 66th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting, San Francisco, CA, 16 November 2015.
-
(2015)
The 66th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting
-
-
Ratziu, V.1
Harrison, S.A.2
Francque, S.M.3
Bedossa, P.4
Serfaty, L.5
Romero-Gomez, M.6
Cales, P.7
Abdelmalek, M.F.8
Caldwell, S.H.9
Drenth, J.10
Anstee, Q.M.11
Hum, D.W.12
Hanf, R.13
Roudot, A.14
Megnien, S.15
Staels, B.16
Sanyal, A.17
-
85
-
-
84859003663
-
Effects of glucagon-like peptide-1 receptor agonists on weight loss: Systematic review and meta-analyses of randomised controlled trials
-
T. Vilsbøll, M. Christensen, A. E. Junker, F. K. Knop, L. L. Gluud, Effects of glucagon-like peptide-1 receptor agonists on weight loss: Systematic review and meta-analyses of randomised controlled trials. BMJ 344, d7771 (2012).
-
(2012)
BMJ
, vol.344
, pp. d7771
-
-
Vilsbøll, T.1
Christensen, M.2
Junker, A.E.3
Knop, F.K.4
Gluud, L.L.5
-
86
-
-
84936166069
-
A randomized, controlled trial of 3.0 mg of liraglutide in weight management
-
SCALE Obesity and Prediabetes NN8022-1839 Study Group
-
X. Pi-Sunyer, A. Astrup, K. Fujioka, F. Greenway, A.Halpern, M. Krempf, D. C. W. Lau, C. W. le Roux, R. Violante Ortiz, C. B. Jensen, J. P. H. Wilding; SCALE Obesity and Prediabetes NN8022-1839 Study Group, A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N. Engl. J. Med. 373, 11-22 (2015).
-
(2015)
N. Engl. J. Med
, vol.373
, pp. 11-22
-
-
Pi-Sunyer, X.1
Astrup, A.2
Fujioka, K.3
Greenway, F.4
Halpern, A.5
Krempf, M.6
Lau, D.C.W.7
Le Roux, C.W.8
Violante Ortiz, R.9
Jensen, C.B.10
Wilding, J.P.H.11
-
87
-
-
84864861866
-
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
-
G. Porez, J. Prawitt, B. Gross, B. Staels, Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. J. Lipid Res. 53, 1723-1737 (2012).
-
(2012)
J. Lipid Res
, vol.53
, pp. 1723-1737
-
-
Porez, G.1
Prawitt, J.2
Gross, B.3
Staels, B.4
-
88
-
-
84858796689
-
Transcriptional integration of metabolism by the nuclear sterolactivated receptors LXR and FXR
-
A. C. Calkin, P. Tontonoz, Transcriptional integration of metabolism by the nuclear sterolactivated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. 13, 213-224 (2012).
-
(2012)
Nat. Rev. Mol. Cell Biol
, vol.13
, pp. 213-224
-
-
Calkin, A.C.1
Tontonoz, P.2
-
89
-
-
84929266699
-
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial
-
NASH Clinical Research Network
-
B. A.Neuschwander-Tetri, R. Loomba, A. J. Sanyal, J. E. Lavine, M. L. Van Natta, M. F. Abdelmalek, N. Chalasani, S. Dasarathy, A. M. Diehl, B. Hameed, K. V. Kowdley, A. McCullough, N. Terrault, J. M. Clark, J. Tonascia, E. M. Brunt, D. E. Kleiner, E. Doo; NASH Clinical Research Network, Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial. Lancet 385, 956-965 (2015).
-
(2015)
Lancet
, vol.385
, pp. 956-965
-
-
Neuschwander-Tetri, B.A.1
Loomba, R.2
Sanyal, A.J.3
Lavine, J.E.4
Van Natta, M.L.5
Abdelmalek, M.F.6
Chalasani, N.7
Dasarathy, S.8
Diehl, A.M.9
Hameed, B.10
Kowdley, K.V.11
McCullough, A.12
Terrault, N.13
Clark, J.M.14
Tonascia, J.15
Brunt, E.M.16
Kleiner, D.E.17
Doo, E.18
-
90
-
-
65049089113
-
Regulation of glutathione synthesis
-
S. C. Lu, Regulation of glutathione synthesis. Mol. Aspects Med. 30, 42-59 (2009).
-
(2009)
Mol. Aspects Med
, vol.30
, pp. 42-59
-
-
Lu, S.C.1
-
91
-
-
0019940282
-
Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis
-
W. A. Gahl, N. Bashan, F. Tietze, I. Bernardini, J. D. Schulman, Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 217, 1263-1265 (1982).
-
(1982)
Science
, vol.217
, pp. 1263-1265
-
-
Gahl, W.A.1
Bashan, N.2
Tietze, F.3
Bernardini, I.4
Schulman, J.D.5
-
92
-
-
41049099937
-
Antioxidant effect of cysteamine in brain cortex of young rats
-
A. Kessler, M. Biasibetti, D. A. da Silva Melo, M. Wajner, C. S. Dutra-Filho, Â. T. de Souza Wyse, C. M. D. Wannmacher, Antioxidant effect of cysteamine in brain cortex of young rats. Neurochem. Res. 33, 737-744 (2008).
-
(2008)
Neurochem. Res.
, vol.33
, pp. 737-744
-
-
Kessler, A.1
Biasibetti, M.2
Da Silva Melo, D.A.3
Wajner, M.4
Dutra-Filho, C.S.5
De Wyse Souza, A.T.6
Wannmacher, C.M.D.7
-
93
-
-
79953723142
-
Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease
-
R. Dohil, S. Schmeltzer, B. L. Cabrera, T. Wang, J. Durelle, K. B. Duke, J. B. Schwimmer, J. E. Lavine, Enteric-coated cysteamine for the treatment of paediatric non-alcoholic fatty liver disease. Aliment. Pharmacol. Ther. 33, 1036-1044 (2011).
-
(2011)
Aliment. Pharmacol. Ther
, vol.33
, pp. 1036-1044
-
-
Dohil, R.1
Schmeltzer, S.2
Cabrera, B.L.3
Wang, T.4
Durelle, J.5
Duke, K.B.6
Schwimmer, J.B.7
Lavine, J.E.8
-
94
-
-
84879442146
-
Gut microbiota after gastric bypass in human obesity: Increased richness and associations of bacterial genera with adipose tissue genes
-
L.-C. Kong, J. Tap, J. Aron-Wisnewsky, V. Pelloux, A. Basdevant, J.-L. Bouillot, J.-D. Zucker, J. Doré, K. Clément, Gut microbiota after gastric bypass in human obesity: Increased richness and associations of bacterial genera with adipose tissue genes. Am. J. Clin. Nutr. 98, 16-24 (2013).
-
(2013)
Am. J. Clin. Nutr
, vol.98
, pp. 16-24
-
-
Kong, L.-C.1
Tap, J.2
Aron-Wisnewsky, J.3
Pelloux, V.4
Basdevant, A.5
Bouillot, J.-L.6
Zucker, J.-D.7
Doré, J.8
Clément, K.9
-
95
-
-
23344442120
-
Obesity alters gut microbial ecology
-
R. E. Ley, F. Bäckhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight, J. I. Gordon, Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102, 11070-11075 (2005).
-
(2005)
Proc. Natl. Acad. Sci. U.S.A
, vol.102
, pp. 11070-11075
-
-
Ley, R.E.1
Bäckhed, F.2
Turnbaugh, P.3
Lozupone, C.A.4
Knight, R.D.5
Gordon, J.I.6
-
96
-
-
69149083245
-
TGR5-mediated bile acid sensing controls glucose homeostasis
-
C. Thomas, A. Gioiello, L. Noriega, A. Strehle, J. Oury, G. Rizzo, A. Macchiarulo, H. Yamamoto, C. Mataki, M. Pruzanski, R. Pellicciari, J. Auwerx, K. Schoonjans, TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 10, 167-177 (2009).
-
(2009)
Cell Metab
, vol.10
, pp. 167-177
-
-
Thomas, C.1
Gioiello, A.2
Noriega, L.3
Strehle, A.4
Oury, J.5
Rizzo, G.6
Macchiarulo, A.7
Yamamoto, H.8
Mataki, C.9
Pruzanski, M.10
Pellicciari, R.11
Auwerx, J.12
Schoonjans, K.13
-
97
-
-
31444454037
-
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
-
M. Watanabe, S. M. Houten, C. Mataki, M. A. Christoffolete, B. W. Kim, H. Sato, N. Messaddeq, J.W. Harney, O. Ezaki, T. Kodama, K. Schoonjans, A. C. Bianco, J. Auwerx, Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484-489 (2006).
-
(2006)
Nature
, vol.439
, pp. 484-489
-
-
Watanabe, M.1
Houten, S.M.2
Mataki, C.3
Christoffolete, M.A.4
Kim, B.W.5
Sato, H.6
Messaddeq, N.7
Harney, J.W.8
Ezaki, O.9
Kodama, T.10
Schoonjans, K.11
Bianco, A.C.12
Auwerx, J.13
-
98
-
-
77952565420
-
The role of cytokines in non-alcoholic fatty liver disease
-
H. Tilg, The role of cytokines in non-alcoholic fatty liver disease. Dig. Dis. 28, 179-185 (2010).
-
(2010)
Dig. Dis
, vol.28
, pp. 179-185
-
-
Tilg, H.1
-
99
-
-
33646882162
-
Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: A pilot study
-
M. Capanni, F. Calella, M. R. Biagini, S. Genise, L. Raimondi, G. Bedogni, G. Svegliati-Baroni, F. Sofi, S. Milani, R. Abbate, C. Surrenti, A. Casini, Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: A pilot study. Aliment. Pharmacol. Ther. 23, 1143-1151 (2006).
-
(2006)
Aliment. Pharmacol. Ther
, vol.23
, pp. 1143-1151
-
-
Capanni, M.1
Calella, F.2
Biagini, M.R.3
Genise, S.4
Raimondi, L.5
Bedogni, G.6
Svegliati-Baroni, G.7
Sofi, F.8
Milani, S.9
Abbate, R.10
Surrenti, C.11
Casini, A.12
-
100
-
-
78649823911
-
Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: A preliminary study
-
F. Sofi, I. Giangrandi, F. Cesari, I. Corsani, R. Abbate, G. F. Gensini, A. Casini, Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: A preliminary study. Int. J. Food Sci. Nutr. 61, 792-802 (2010).
-
(2010)
Int. J. Food Sci. Nutr
, vol.61
, pp. 792-802
-
-
Sofi, F.1
Giangrandi, I.2
Cesari, F.3
Corsani, I.4
Abbate, R.5
Gensini, G.F.6
Casini, A.7
-
101
-
-
38749115791
-
Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
-
L. Spadaro, O. Magliocco, D. Spampinato, S. Piro, C. Oliveri, C. Alagona, G. Papa, A. M. Rabuazzo, F. Purrello, Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig. Liver Dis. 40, 194-199 (2008).
-
(2008)
Dig. Liver Dis
, vol.40
, pp. 194-199
-
-
Spadaro, L.1
Magliocco, O.2
Spampinato, D.3
Piro, S.4
Oliveri, C.5
Alagona, C.6
Papa, G.7
Rabuazzo, A.M.8
Purrello, F.9
-
102
-
-
79959446947
-
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: A randomized controlled trial
-
L. B. Van Wagner, S. W. P. Koppe, E. M. Brunt, J. Gottstein, K. Gardikiotes, R. M. Green, M. E. Rinella, Pentoxifylline for the treatment of non-alcoholic steatohepatitis: A randomized controlled trial. Ann. Hepatol. 10, 277-286 (2011).
-
(2011)
Ann. Hepatol
, vol.10
, pp. 277-286
-
-
Van Wagner, L.B.1
Koppe, S.W.P.2
Brunt, E.M.3
Gottstein, J.4
Gardikiotes, K.5
Green, R.M.6
Rinella, M.E.7
-
103
-
-
80055028155
-
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
-
C. O. Zein, L. M. Yerian, P. Gogate, R. Lopez, J. P. Kirwan, A. E. Feldstein, A. J. McCullough, Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial. Hepatology 54, 1610-1619 (2011).
-
(2011)
Hepatology
, vol.54
, pp. 1610-1619
-
-
Zein, C.O.1
Yerian, L.M.2
Gogate, P.3
Lopez, R.4
Kirwan, J.P.5
Feldstein, A.E.6
McCullough, A.J.7
-
104
-
-
84867165316
-
Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism
-
C. O. Zein, R. Lopez, X. Fu, J. P. Kirwan, L. M. Yerian, A. J. McCullough, S. L. Hazen, A. E. Feldstein, Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism. Hepatology 56, 1291-1299 (2012).
-
(2012)
Hepatology
, vol.56
, pp. 1291-1299
-
-
Zein, C.O.1
Lopez, R.2
Fu, X.3
Kirwan, J.P.4
Yerian, L.M.5
McCullough, A.J.6
Hazen, S.L.7
Feldstein, A.E.8
-
105
-
-
84873990663
-
Review of the key results from the Swedish Obese Subjects (SOS) trial - A prospective controlled intervention study of bariatric surgery
-
L. Sjöström, Review of the key results from the Swedish Obese Subjects (SOS) trial-a prospective controlled intervention study of bariatric surgery. J. Intern. Med. 273, 219-234 (2013).
-
(2013)
J. Intern. Med
, vol.273
, pp. 219-234
-
-
Sjöström, L.1
-
106
-
-
84889773510
-
Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity
-
Longitudinal Assessment of Bariatric Surgery (LABS) Consortium
-
A. P. Courcoulas, N. J. Christian, S. H. Belle, P. D. Berk, D. R. Flum, L. Garcia, M. Horlick, M. A. Kalarchian, W. C. King, J. E. Mitchell, E. J. Patterson, J. R. Pender, A. Pomp, W. J. Pories, R. C. Thirlby, S. Z. Yanovski, B. M. Wolfe; Longitudinal Assessment of Bariatric Surgery (LABS) Consortium, Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA 310, 2416-2425 (2013).
-
(2013)
JAMA
, vol.310
, pp. 2416-2425
-
-
Courcoulas, A.P.1
Christian, N.J.2
Belle, S.H.3
Berk, P.D.4
Flum, D.R.5
Garcia, L.6
Horlick, M.7
Kalarchian, M.A.8
King, W.C.9
Mitchell, J.E.10
Patterson, E.J.11
Pender, J.R.12
Pomp, A.13
Pories, W.J.14
Thirlby, R.C.15
Yanovski, S.Z.16
Wolfe, B.M.17
-
107
-
-
67650951419
-
Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease
-
P. Mathurin, A. Hollebecque, L. Arnalsteen, D. Buob, E. Leteurtre, R. Caiazzo, M. Pigeyre, H. Verkindt, S. Dharancy, A. Louvet, M. Romon, F. Pattou, Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 137, 532-540 (2009).
-
(2009)
Gastroenterology
, vol.137
, pp. 532-540
-
-
Mathurin, P.1
Hollebecque, A.2
Arnalsteen, L.3
Buob, D.4
Leteurtre, E.5
Caiazzo, R.6
Pigeyre, M.7
Verkindt, H.8
Dharancy, S.9
Louvet, A.10
Romon, M.11
Pattou, F.12
-
108
-
-
84926122690
-
Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: A 5-year controlled longitudinal study
-
R. Caiazzo, G. Lassailly, E. Leteurtre, G. Baud, H. Verkindt, V. Raverdy, D. Buob, M. Pigeyre, P. Mathurin, F. Pattou, Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: A 5-year controlled longitudinal study. Ann. Surg. 260, 893-898 (2014).
-
(2014)
Ann. Surg
, vol.260
, pp. 893-898
-
-
Caiazzo, R.1
Lassailly, G.2
Leteurtre, E.3
Baud, G.4
Verkindt, H.5
Raverdy, V.6
Buob, D.7
Pigeyre, M.8
Mathurin, P.9
Pattou, F.10
-
109
-
-
84938070225
-
Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients
-
G. Lassailly, R. Caiazzo, D. Buob, M. Pigeyre, H. Verkindt, J. Labreuche, V. Raverdy, E. Leteurtre, S. Dharancy, A. Louvet, M. Romon, A. Duhamel, F. Pattou, P. Mathurin, Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients. Gastroenterology 149, 379-388 (2015).
-
(2015)
Gastroenterology
, vol.149
, pp. 379-388
-
-
Lassailly, G.1
Caiazzo, R.2
Buob, D.3
Pigeyre, M.4
Verkindt, H.5
Labreuche, J.6
Raverdy, V.7
Leteurtre, E.8
Dharancy, S.9
Louvet, A.10
Romon, M.11
Duhamel, A.12
Pattou, F.13
Mathurin, P.14
-
110
-
-
84978910811
-
The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome
-
N. E. Aguilar-Olivos, P. Almeda-Valdes, C. A. Aguilar-Salinas, M. Uribe, N. Méndez-Sánchez, The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. Metabolism 10.1016/j.metabol.2015.09.004 (2015).
-
(2015)
Metabolism
-
-
Aguilar-Olivos, N.E.1
Almeda-Valdes, P.2
Aguilar-Salinas, C.A.3
Uribe, M.4
Méndez-Sánchez, N.5
-
112
-
-
84864773072
-
MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis
-
W.-C. Tsai, S.-D. Hsu, C.-S. Hsu, T.-C. Lai, S.-J. Chen, R. Shen, Y. Huang, H.-C. Chen, C.-H. Lee, T.-F. Tsai, M.-T. Hsu, J.-C. Wu, H.-D. Huang, M.-S. Shiao, M. Hsiao, A.-P. Tsou, MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122, 2884-2897 (2012).
-
(2012)
J. Clin. Invest
, vol.122
, pp. 2884-2897
-
-
Tsai, W.-C.1
Hsu, S.-D.2
Hsu, C.-S.3
Lai, T.-C.4
Chen, S.-J.5
Shen, R.6
Huang, Y.7
Chen, H.-C.8
Lee, C.-H.9
Tsai, T.-F.10
Hsu, M.-T.11
Wu, J.-C.12
Huang, H.-D.13
Shiao, M.-S.14
Hsiao, M.15
Tsou, A.-P.16
-
113
-
-
77952707662
-
MicroRNA-370 controls the expression of microRNA-122 and Cpt1a and affects lipid metabolism
-
D. Iliopoulos, K. Drosatos, Y. Hiyama, I. J. Goldberg, V. I. Zannis, MicroRNA-370 controls the expression of microRNA-122 and Cpt1a and affects lipid metabolism. J. Lipid Res. 51, 1513-1523 (2010).
-
(2010)
J. Lipid Res.
, vol.51
, pp. 1513-1523
-
-
Iliopoulos, D.1
Drosatos, K.2
Hiyama, Y.3
Goldberg, I.J.4
Zannis, V.I.5
-
114
-
-
58149386462
-
Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression
-
O. Cheung, P. Puri, C. Eicken, M. J. Contos, F. Mirshahi, J. W. Maher, J. M. Kellum, H. Min, V. A. Luketic, A. J. Sanyal, Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression. Hepatology 48, 1810-1820 (2008).
-
(2008)
Hepatology
, vol.48
, pp. 1810-1820
-
-
Cheung, O.1
Puri, P.2
Eicken, C.3
Contos, M.J.4
Mirshahi, F.5
Maher, J.W.6
Kellum, J.M.7
Min, H.8
Luketic, V.A.9
Sanyal, A.J.10
-
115
-
-
84994813767
-
Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARa expression
-
X. Loyer, V. Paradis, C. Hénique, A.-C. Vion, N. Colnot, C. L. Guerin, C. Devue, S. On, J. Scetbun, M. Romain, J.-L. Paul, M. E. Rothenberg, P. Marcellin, F. Durand, P. Bedossa, C. Prip-Buus, E. Baugé, B. Staels, C. M. Boulanger, A. Tedgui, P.-E. Rautou, Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARa expression. Gut, pii: gutjnl-2014-308883 (2015).
-
(2015)
Gut
-
-
Loyer, X.1
Paradis, V.2
Hénique, C.3
Vion, A.-C.4
Colnot, N.5
Guerin, C.L.6
Devue, C.7
On, S.8
Scetbun, J.9
Romain, M.10
Paul, J.-L.11
Rothenberg, M.E.12
Marcellin, P.13
Durand, F.14
Bedossa, P.15
Prip-Buus, C.16
Baugé, E.17
Staels, B.18
Boulanger, C.M.19
Tedgui, A.20
Rautou, P.-E.21
more..
-
116
-
-
84924778498
-
Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
-
R. J. Perry, D. Zhang, X.-M. Zhang, J. L. Boyer, G. I. Shulman, Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats. Science 347, 1253-1256 (2015).
-
(2015)
Science
, vol.347
, pp. 1253-1256
-
-
Perry, R.J.1
Zhang, D.2
Zhang, X.-M.3
Boyer, J.L.4
Shulman, G.I.5
-
117
-
-
84899725600
-
Genetic polymorphism of cytochrome P450 4F2, Vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials
-
S. Athinarayanan, R. Wei, M. Zhang, S. Bai, M. G. Traber, K. Yates, O. W. Cummings, J. Molleston, W. Liu, N. Chalasani, Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials. PLOS One 9, e95366 (2014).
-
(2014)
PLOS One
, vol.9
, pp. e95366
-
-
Athinarayanan, S.1
Wei, R.2
Zhang, M.3
Bai, S.4
Traber, M.G.5
Yates, K.6
Cummings, O.W.7
Molleston, J.8
Liu, W.9
Chalasani, N.10
-
118
-
-
84866556907
-
Metabolomic profiling to identify predictors of response to Vitamin E for non-alcoholic steatohepatitis (NASH)
-
J. Cheng, A. Joyce, K. Yates, B. Aouizerat, A. J. Sanyal, Metabolomic profiling to identify predictors of response to vitamin E for non-alcoholic steatohepatitis (NASH). PLOS One 7, e44106 (2012).
-
(2012)
PLOS One
, vol.7
, pp. e44106
-
-
Cheng, J.1
Joyce, A.2
Yates, K.3
Aouizerat, B.4
Sanyal, A.J.5
|